These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36822892)

  • 21. Whipple's disease review, prevalence, mortality, and characteristics in the United States: A cross-sectional national inpatient study.
    Ahmad AI; Wikholm C; Pothoulakis I; Caplan C; Lee A; Buchanan F; Kyoo Cho W
    Medicine (Baltimore); 2022 Dec; 101(49):e32231. PubMed ID: 36626499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tropheryma whipplei and Whipple's disease.
    Fenollar F; Lagier JC; Raoult D
    J Infect; 2014 Aug; 69(2):103-12. PubMed ID: 24877762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whipple's disease and Tropheryma whipplei infections: from bench to bedside.
    Boumaza A; Ben Azzouz E; Arrindell J; Lepidi H; Mezouar S; Desnues B
    Lancet Infect Dis; 2022 Oct; 22(10):e280-e291. PubMed ID: 35427488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythema nodosum-like lesions in treated Whipple's disease: signs of immune reconstitution inflammatory syndrome.
    Schaller J; Carlson JA
    J Am Acad Dermatol; 2009 Feb; 60(2):277-88. PubMed ID: 19150271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor Necrosis Factor Inhibitors Exacerbate Whipple's Disease by Reprogramming Macrophage and Inducing Apoptosis.
    Boumaza A; Mezouar S; Bardou M; Raoult D; Mège JL; Desnues B
    Front Immunol; 2021; 12():667357. PubMed ID: 34093562
    [No Abstract]   [Full Text] [Related]  

  • 26. Constrictive pleuropericarditis: a dominant clinical manifestation in Whipple's disease.
    Stojan G; Melia MT; Khandhar SJ; Illei P; Baer AN
    BMC Infect Dis; 2013 Dec; 13():579. PubMed ID: 24321135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of Whipple's Disease in the USA Between 2012 and 2017: A Population-Based National Study.
    Elchert JA; Mansoor E; Abou-Saleh M; Cooper GS
    Dig Dis Sci; 2019 May; 64(5):1305-1311. PubMed ID: 30488239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tropheryma whipplei aortic valve endocarditis without systemic Whipple's disease.
    Chan V; Wang B; Veinot JP; Suh KN; Rose G; Desjardins M; Mesana TG
    Int J Infect Dis; 2011 Nov; 15(11):e804-6. PubMed ID: 21880531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Whipple's disease].
    Martin-Iguacel R; Clark PS; Barfod TS
    Ugeskr Laeger; 2014 Jan; 176(2A):V05130309. PubMed ID: 25346310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whipple's Disease Presenting With a Chief Complaint of Dyspnea and Cough From Pulmonary Invasion Without Evidence of Gastrointestinal Involvement.
    Ladna M; George J; Forsmark CE
    Cureus; 2024 Feb; 16(2):e54554. PubMed ID: 38516502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tropheryma whipplei infection and Whipple's disease.
    Marth T; Moos V; Müller C; Biagi F; Schneider T
    Lancet Infect Dis; 2016 Mar; 16(3):e13-22. PubMed ID: 26856775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Another Whipple's triad? Pericardial, myocardial and valvular disease in an unusual case presentation from a Canadian perspective.
    Thornton CS; Wang Y; Köebel M; Bernard K; Burdz T; Maitland A; Ferraz JG; Beck PL; Ferland A
    BMC Cardiovasc Disord; 2019 Dec; 19(1):312. PubMed ID: 31870305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whipple's disease.
    Laeeq SM; Luck NH; Hassan SM; Abbas Z; Tasneem AA; Mubarak M
    J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S81-3. PubMed ID: 24906280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ophthalmic manifestations of Whipple's disease.
    Rasool N
    Curr Opin Ophthalmol; 2024 Jan; 35(1):83-88. PubMed ID: 37830937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired immune functions of monocytes and macrophages in Whipple's disease.
    Moos V; Schmidt C; Geelhaar A; Kunkel D; Allers K; Schinnerling K; Loddenkemper C; Fenollar F; Moter A; Raoult D; Ignatius R; Schneider T
    Gastroenterology; 2010 Jan; 138(1):210-20. PubMed ID: 19664628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease.
    Feurle GE; Junga NS; Marth T
    Gastroenterology; 2010 Feb; 138(2):478-86; quiz 11-2. PubMed ID: 19879276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whipple's disease: Rare case of malabsorption with hyperpigmentation in a female.
    Munjal Y; Munjal SD; Tiwari R
    Indian J Pathol Microbiol; 2021; 64(4):788-790. PubMed ID: 34673605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease.
    Moos V; Kunkel D; Marth T; Feurle GE; LaScola B; Ignatius R; Zeitz M; Schneider T
    J Immunol; 2006 Aug; 177(3):2015-22. PubMed ID: 16849516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurologic disease in patients with treated Whipple's disease.
    Knox DL; Bayless TM; Pittman FE
    Medicine (Baltimore); 1976 Nov; 55(6):467-76. PubMed ID: 63101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tropheryma whipplei as a commensal bacterium.
    Keita AK; Raoult D; Fenollar F
    Future Microbiol; 2013 Jan; 8(1):57-71. PubMed ID: 23252493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.